United Kingdom· GB-APID-14231311000001100
Exocin 0.3% eye drops
A ofloxacin product containing ofloxacin, registered in United Kingdom by Sigma Pharmaceuticals Plc. The same ATC class is registered in 11 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Ofloxacin is registered in 11 of 19 countries.
Countries holding a registration under ATC S01AE01 (ofloxacin), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 6 of them publish a price we can compare per daily dose
Ofloxacin · ATC S01AE01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Germany
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Ofloxacin
- Manufacturer
- Sigma Pharmaceuticals Plc
- Country
- United Kingdom (GB)
- ATC code
- S01AE01
- ATC class
- Ofloxacin
- Defined daily dose
- 0.4 mg, AT
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ofloxacin in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandFloxalDr Gerhard Mann Chem. - Pharm. Fabrik GmbH
- United StatesOCUFLOXAllergan, Inc.
- GermanyFloxalDr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh
- FranceEXOCINE 0,3 POUR CENT, collyreABBVIE
- BelgiumOfloxacin-Pos 3 mg/mlURSAPHARM Benelux
- Japanオフロキサシン沢井製薬
- NetherlandsOfloxacine 200 PCH, filmomhulde tabletten 200 mgPharmachemie B.V.
- SpainEXOCIN 3 MG/ML COLIRIO EN SOLUCIONAbbvie Spain, S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Floxal, Floxal Edo
- Belgium · Trafloxal, Trafloxal Edo
- Bulgaria · Медофлоксин, Офлоксацин Дра
- Cyprus · Cilox, Medofloxine
- Czechia · Floxal, Ofloxacin Unimed Pharma
- Germany · Floxal, Floxal Edo
- Estonia · Medofloxine, Ofloxin
- Spain · Exocin, Oflovir
- Finland · Exocin
- France · Exocine, Monoflocet
- Greece · Exocin, Oxatrex
- Croatia · Uniflox
- Hungary · Floxal, Grenis-Oflo
- Ireland · Exocin
- Italy · Dunaflot, Exocin
- Lithuania · Ofloxin, Uniflox
- Luxembourg · Ofloxa-Vision Kombi-Packung, Visioflox
- Latvia · Ofloxin, Uniflox
- Malta · Uniflox Unimed Pharma
- Netherlands · Ofloxacine 200 Pch, Ofloxacine 400 Pch
- Poland · Floxal, Oflodinex
- Portugal · Audret, Bioquil
- Romania · Floxal, Ofloxacină Laropharm
- Sweden · Ofloxacin Mibe
- Slovakia · Medofloxine, Ofloxin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d3e70345-aa8a-41f7-99c5-2e81d5bfee2c GET /v1/drugs/d3e70345-aa8a-41f7-99c5-2e81d5bfee2c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "14231311000001100",
"desc": "Exocin 0.3% eye drops (Sigma Pharmaceuticals Plc)",
"form": "Eye drops",
"vpid": "42193411000001106",
"source": "dmd",
"vtm_id": "776973005",
"strength": "3 mg",
"substance": "Ofloxacin",
"ingredient": "Ofloxacin",
"supplier_code": "2087601000001106"
}See everything about ofloxacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.